Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Sees Significant Growth in Short Interest

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 17,416 shares, an increase of 387.7% from the July 15th total of 3,571 shares. Based on an average daily volume of 77,992 shares, the days-to-cover ratio is presently 0.2 days. Approximately 1.9% of the shares of the company are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded Cuprina Holdings (Cayman) from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, July 17th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Cuprina Holdings (Cayman) currently has a consensus rating of “Sell”.

Cuprina Holdings (Cayman) Stock Performance

NASDAQ:CUPR remained flat at $2.98 during mid-day trading on Wednesday. 83,315 shares of the company traded hands, compared to its average volume of 1,383,844. The stock has a 50-day moving average of $4.10. The company has a current ratio of 2.35, a quick ratio of 2.35 and a debt-to-equity ratio of 0.07. Cuprina Holdings has a 12 month low of $1.76 and a 12 month high of $76.00.

About Cuprina Holdings (Cayman)

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.